Advertisement
In 2018

CDC: Uninsurance Levels Did Not Change Significantly in 2018

0
Uninsurance increased among adults aged 45 to 64 years; increase seen in high-deductible health plans
The American Cancer Society has set a goal of a 40 percent reduction in overall cancer mortality by 2035

ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035

0
Goal based on decrease in overall cancer death rates at pace seen among college graduates
In 2018

2018 Saw More Employed Physicians Than Self-Employed

0
Proportion of physicians working in practices wholly owned by physicians dropped to 54 percent in 2018
For patients with hepatocellular carcinoma

Percutaneous Ablation in Liver Cancer Tied to Better Outcomes

0
Intervention linked to better short-term outcomes versus surgical procedures
In 2015 to 2016

In 2015 to 2016, 45.8 Percent of U.S. Population Used Rx Drugs

0
Prescription drug use increased with age, reaching 85.0 percent for those aged 60 years and older
For morbidly obese patients with atrial fibrillation

Preablation Bariatric Surgery Linked to Reduced A-Fib Recurrence

0
Bariatric surgery was only independent predictor of arrhythmia-free survival in multivariate analysis
Complication rates for nipple-sparing mastectomy are decreasing despite expanded indications for the procedure among higher-risk patients

Less Invasive Mastectomy an Option for More Patients

0
Higher-risk patients may now be eligible for nipple-sparing mastectomy
In response to public demands for action to control drug costs

Prices Will Soon Be Included in TV Drug Ads

0
Regulations will require companies to disclose prices of meds costing more than $35 for a month's supply
The Combat Application Tourniquet is suitable for use in the upper and lower extremities of school-age children

Combat Application Tourniquet Suitable for Use in Children

0
CAT successfully occluded arterial blood flow in all upper extremities, 93 percent of lower extremities
The average price for single-source brand-name drugs is higher in the United States than in other countries

External Reference Pricing Could Cut Drug Costs in U.S.

0
Prices averaged 3.2 to 4.1 times higher in U.S.; differential varied from 1.3 to 70.1 for individual drugs